| SEC Info ||Home||Search||My Interests||Help||Sign In||Please Sign In|
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/10/21 Qualys, Inc. 8-K:2,5,9 2/07/21 12:402K Donnelley … Solutions/FA
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 27K 2: EX-99.1 Miscellaneous Exhibit HTML 145K 3: EX-99.2 Miscellaneous Exhibit HTML 10K 8: R1 Document and Entity Information HTML 46K 10: XML IDEA XML File -- Filing Summary XML 12K 7: XML XBRL Instance -- d12261d8k_htm XML 13K 9: EXCEL IDEA Workbook of Financial Reports XLSX 6K 5: EX-101.LAB XBRL Labels -- qlys-20210207_lab XML 53K 6: EX-101.PRE XBRL Presentations -- qlys-20210207_pre XML 34K 4: EX-101.SCH XBRL Schema -- qlys-20210207 XSD 12K 11: JSON XBRL Instance as JSON Data -- MetaLinks 12± 18K 12: ZIP XBRL Zipped Folder -- 0001193125-21-036397-xbrl Zip 27K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM i 8-K
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
i Qualys, Inc.
(Exact name of registrant as specified in its charter)
|i Delaware||i 001-35662||i 77-0534145|
(State or other jurisdiction
i 919 East Hillsdale Boulevard
i Foster City, i California i 94404
(Address of principal executive offices, including zip code)
i (650) i 801-6100
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|i ☐|| |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|i ☐|| |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|i ☐|| |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|i ☐|| |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange
on which registered
|i Common stock, $0.001 par value per share||i QLYS||i NASDAQ Stock Market|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company i ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|Item 2.02|| |
Results of Operations and Financial Condition.
On February 10, 2021, Qualys, Inc. (“Qualys” or the “Company”) issued a press release announcing its financial results for the quarter and fiscal year ended December 31, 2020. In the press release, Qualys also announced that it will hold a conference call on February 10, 2021, to discuss its financial results for the quarter and fiscal year ended December 31, 2020. The full text of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
This information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
|Item 5.02|| |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 10, 2021, the Company announced that Philippe Courtot, Chairman of the Board and Chief Executive Officer of the Company, is taking a leave of absence due to health issues unrelated to COVID-19. In connection with Mr. Courtot’s leave of absence, on February 7, 2021, the Qualys Board of Directors (the “Board”) appointed Sumedh Thakar, President and Chief Product Officer of the Company, as interim Chief Executive Officer and principal executive officer. On February 7, 2021, the Board also appointed Mr. Thakar to serve on the Board as a Class III director until the Company’s 2021 annual meeting stockholders or until his successor is duly elected and qualified.
Mr. Thakar, age 45, has served as the Company’s President since October 2019 and Chief Product Officer since June 2014. From December 2010 to June 2014, Mr. Thakar served as the Company’s Vice President, Engineering. Mr. Thakar joined the Company in February 2003 and has held various positions with the Company since that time, including Principal Engineer, Engineering Manager and Director of Engineering. Mr. Thakar holds a Bachelor of Computer Science degree from the University of Pune, India.
There are no arrangements or understandings between Mr. Thakar and any other persons pursuant to which he was elected to serve on the Board. Mr. Thakar is not a party to any transaction with any related person required to be disclosed pursuant to Item 404(a) of Regulation S-K promulgated by the Securities and Exchange Commission.
|Item 9.01|| |
Financial Statements and Exhibits.
|99.1||Press release dated February 10, 2021, entitled “Qualys Announces Fourth Quarter and Full Year 2020 Financial Results”|
|99.2||Press release dated February 10, 2021, entitled “Qualys Chairman and Chief Executive Officer Philippe Courtot to Take a Medical Leave of Absence”|
|104||Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)|
|This ‘8-K’ Filing||Date||Other Filings|
|Filed on:||2/10/21||SC 13G/A|
|For Period end:||2/7/21|
|List all Filings|
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/22/21 Qualys, Inc. S-8 2/22/21 3:69K Donnelley … Solutions/FA